Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline for Smoking Cessation in Elective Surgery Patients
NCT00889720Phase 4Completed
- Sponsor
- Pfizer
- Start
- Nov 2009
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, open-label, single-arm trial of varenicline in nicotine dependence, sponsored by Pfizer. Primary endpoints: Percentage of Fully Compliant Participants, Number of Participants With Surgical Site Infection at Week 26 and 4 more. Started Nov 2009; status: completed.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00889720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00889720.